Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam versus propofol for ICU sedation in mechanically ventilated patients
ChiCTR2100046214Phase 4Recruiting
- Sponsor
- Affiliated Hospital of Guizhou Medical University
- Start
- May 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of remimazolam and propofol in critical illness (2 arms), sponsored by Affiliated Hospital of Guizhou Medical University. Primary endpoints: Percentage of time spent maintaining the target sedation range and Number of rescue interventions and rescue cases. Started May 2021; status: recruiting.
02
Drugs
remimazolampropofol
03
Conditions
critical illness
Beyond the preview
Go deeper on ChiCTR2100046214.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100046214.